UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?

Annals of oncology, 2021-02, Vol.32 (2), p.279-280

2021

Link zum Volltext

Verfügbarkeit prüfen

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4

Leukemia, 2012-01, Vol.26 (1), p.34-53

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Single-Agent Concurrent Chemotherapy on Survival in Anaplastic Oligodendroglioma: A Review of the National Cancer Data Base

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E76-E77

2016

Link zum Volltext

Verfügbarkeit prüfen

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Annals of oncology, 2018-10, Vol.29, p.viii453-viii453

2018

Link zum Volltext

Verfügbarkeit prüfen

Imaging Changes Following Proton Radiation Therapy in Adult Diffuse Gliomas

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E106-E106

2016

Link zum Volltext

Verfügbarkeit prüfen

278O Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295

Annals of oncology, 2022-09, Vol.33, p.S666

2022

Link zum Volltext

Verfügbarkeit prüfen

LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response

Annals of oncology, 2023-10, Vol.34, p.S1288-S1289

2023

Link zum Volltext

Verfügbarkeit prüfen

814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3

Annals of oncology, 2022-09, Vol.33, p.S918-S919

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes of Reirradiation in IDH-Mutant Astrocytomas and 1p/19q Codeleted Oligodendrogliomas

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e342-e342

2018

Link zum Volltext

Verfügbarkeit prüfen

Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e565-e566

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5569-5569

2011

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

EJC skin cancer, 2024, Vol.2, p.100213, Article 100213

2024

Link zum Volltext

Verfügbarkeit prüfen

A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

EJC skin cancer, 2024, Vol.2

2024

Link zum Volltext

Verfügbarkeit prüfen

1268PNCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

Cancer discovery, 2016-11, Vol.6 (11), p.1230-1236

2016

Link zum Volltext

Verfügbarkeit prüfen

Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy

Radiotherapy and oncology, 2018-05, Vol.127 (2), p.310-317

2018

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2058-2058

2022

Link zum Volltext

Verfügbarkeit prüfen

(P60) Targeting Radiation Therapy to Soft Tissue Lesions Prior to the Start of Immunotherapy Improves Survival in Extracranial Metastatic Melanoma

International journal of radiation oncology, biology, physics, 2018-06, Vol.101 (2), p.E43-E44

2018

Link zum Volltext

Verfügbarkeit prüfen

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Journal of clinical oncology, 2023-01, Vol.41 (3), p.618-628

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma

International journal of radiation oncology, biology, physics, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS2070-TPS2070

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2040-2040

2021

Link zum Volltext

Verfügbarkeit prüfen

A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2033-2033

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

Journal of neuro-oncology, 2017-02, Vol.131 (3), p.593-601

2017

Link zum Volltext

Verfügbarkeit prüfen

Tu1159 MULTICENTER EVALUATION OF THE PERFORMANCE OF PARTIALLY VERSUS FULLY COVERED SELF-EXPANDING METAL STENTS (SEMS) AND IMPACT ON NUTRITIONAL STATUS IN PATIENTS WITH MALIGNANT ESOPHAGEAL OBSTRUCTION

Gastrointestinal endoscopy, 2018-06, Vol.87 (6), p.AB547-AB548

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Oncology
(8)
Humans
(5)
Clinical Neurology
(4)
Neurosciences & Neurology
(4)
Chemotherapy
(3)
Immunotherapy
(3)
Clinical Investigations
(2)
Gbm
(2)
Glioblastoma - Drug Therapy
(2)
Hematology, Oncology And Palliative Medicine
(2)
Male
(2)
Mutation
(2)
Ncdb
(2)
Radiation Therapy
(2)
Radiology
(2)
Salvage Therapy
(2)
Abscopal Effect
(1)
Adult
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4

Effect of Single-Agent Concurrent Chemotherapy on Survival in Anaplastic Oligodendroglioma: A Review of the National Cancer Data Base

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Imaging Changes Following Proton Radiation Therapy in Adult Diffuse Gliomas

278O Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295

LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response

814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3

Clinical Outcomes of Reirradiation in IDH-Mutant Astrocytomas and 1p/19q Codeleted Oligodendrogliomas

Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy

Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)

A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

A-305 - A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma

1268PNCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy

Preliminary results of a phase II study of retifanlimab (PD-1 inhibitor) plus or minus epacadostat (IDO1 inhibitor) in combination with bevacizumab and hypofractionated radiotherapy for recurrent glioblastoma: NCT03532295

(P60) Targeting Radiation Therapy to Soft Tissue Lesions Prior to the Start of Immunotherapy Improves Survival in Extracranial Metastatic Melanoma

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma

A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data

A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma

Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base

Tu1159 MULTICENTER EVALUATION OF THE PERFORMANCE OF PARTIALLY VERSUS FULLY COVERED SELF-EXPANDING METAL STENTS (SEMS) AND IMPACT ON NUTRITIONAL STATUS IN PATIENTS WITH MALIGNANT ESOPHAGEAL OBSTRUCTION

Suchergebnisse filtern